Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8962284 | Vaccine | 2018 | 6 Pages |
Abstract
The proportion of the population â¥65â¯years old is about 17% today and will be about 27% in 2050 worldwide. The problem, however, is not ageing in itself, it is individual disabilities associated with ageing. This manuscript summarizes the consensus points reached during a pan-European meeting on gaps and barriers in making vaccination of adults aged 50+ a reality and on further joint actions in Europe. The shift from childhood to life-long vaccination is essential to prevent disability, morbidity and mortality in the elderly and promote healthy ageing. This vaccination shift is a major challenge in the post-truth, media-based era in countries with dwindling resources for the provision of healthcare. The challenge can be met only by adopting an innovative approach designed to shift the mindset of decision-makers from treatment to prevention. A number of key actions are required and for these actions a European multidisciplinary network including health authorities, medical doctors with different specialties, sociologists, psychologists, pharmaceutical companies and Associations of patients appears mandatory.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Susanna Esposito, Nicola Principi, Giovanni Rezza, Paolo Bonanni, Gaetan Gavazzi, Ingo Beyer, Michael Sulzner, Lucia Pastore Celentano, Roman Prymula, Andrea Rappagliosi, Joseph Sevilla, Gregory Poland,